Last reviewed · How we verify
Diphtheria, pertussis, and tetanus booster vaccine
Diphtheria, pertussis, and tetanus booster vaccine is a Biologic drug developed by Oregon Health and Science University. It is currently FDA-approved. Also known as: Boostrix.
At a glance
| Generic name | Diphtheria, pertussis, and tetanus booster vaccine |
|---|---|
| Also known as | Boostrix |
| Sponsor | Oregon Health and Science University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents (PHASE3)
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (PHASE1)
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children (PHASE2)
- Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand (PHASE3)
- Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines (PHASE1)
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (PHASE3)
- Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diphtheria, pertussis, and tetanus booster vaccine CI brief — competitive landscape report
- Diphtheria, pertussis, and tetanus booster vaccine updates RSS · CI watch RSS
- Oregon Health and Science University portfolio CI
Frequently asked questions about Diphtheria, pertussis, and tetanus booster vaccine
What is Diphtheria, pertussis, and tetanus booster vaccine?
Diphtheria, pertussis, and tetanus booster vaccine is a Biologic drug developed by Oregon Health and Science University.
Who makes Diphtheria, pertussis, and tetanus booster vaccine?
Diphtheria, pertussis, and tetanus booster vaccine is developed and marketed by Oregon Health and Science University (see full Oregon Health and Science University pipeline at /company/oregon-health-and-science-university).
Is Diphtheria, pertussis, and tetanus booster vaccine also known as anything else?
Diphtheria, pertussis, and tetanus booster vaccine is also known as Boostrix.
What development phase is Diphtheria, pertussis, and tetanus booster vaccine in?
Diphtheria, pertussis, and tetanus booster vaccine is FDA-approved (marketed).
Related
- Manufacturer: Oregon Health and Science University — full pipeline
- Also known as: Boostrix
- Compare: Diphtheria, pertussis, and tetanus booster vaccine vs similar drugs
- Pricing: Diphtheria, pertussis, and tetanus booster vaccine cost, discount & access